Cotylenin A

Cotylenin A is a fusicoccane-diterpene glycoside known for its potent plant growth-regulating activity and has garnered significant attention for its promising bioactivity as an anti-cancer agent. The compound was initially isolated from the culture filtrate of a fungus, Cladosporium sp., and has been studied for its various biological effects, including the ability to induce differentiation in several human and murine myeloid leukemia cell lines, stimulate seed germination of certain parasitic plants, and exhibit potent anti-cancer properties[5][6].

Recent scientific efforts have focused on the total synthesis of Cotylenin A due to its complex structure and the challenges associated with its production from natural sources. The fungus that produces Cotylenin A loses its ability to proliferate during preservation, creating a supply shortage. Moreover, the compound's structure, featuring two carbocyclic five-membered rings fused with a carbocyclic eight-membered ring and a uniquely-structured, glucose-based sugar attached, presents significant synthetic challenges[1][4].

Waseda University scientists have developed the world's first method for the total synthesis of Cotylenin A. This breakthrough was reported in the Journal of the American Chemical Society on March 16, 2020. The synthetic method involves separating the structure of Cotylenin A into three fragments, each prepared with commercially-available chemical compounds using different reactions. These fragments are then assembled back together using a coupling reaction, followed by a cyclization of the carbocyclic eight-membered ring mediated by palladium and a coupling with the sugar-part fragment catalyzed by rhodium. The total synthesis initially took about 25 steps, but the team has since succeeded in reducing this to only 20 steps. This method not only provides a steady supply of Cotylenin A but also opens the door for the development of an effective anticancer drug that exhibits stronger anticancer activity and causes no side effects[1][4].

Additionally, other research groups have reported on the synthesis of Cotylenin A and its derivatives. For instance, a concise chemoenzymatic synthesis of cotylenol, the aglycone of Cotylenin A, was reported, highlighting key features that contribute to the brevity of the route, including the union of two cyclopentene fragments and a late-stage enzymatic oxidation[2]. Another study described the convergent total synthesis of (+)-Cotylenin A, employing a catalytic asymmetric intramolecular cyclopropanation for the A-ring fragment and a modified acyl radical cyclization for the C-ring fragment, leading to the successful assembly of the compound[3].

The development of these synthetic methods for Cotylenin A and its derivatives is significant for further biological studies and the potential discovery of new anticancer drugs with enhanced activity and reduced side effects.

Citations:

[1] https://www.waseda.jp/top/en/news/73571

[2] https://chemrxiv.org/engage/chemrxiv/article-details/6332fee8114b7e5fe81f55df

[3] https://link.springer.com/chapter/10.1007/978-981-16-2458-2_7

[4] https://phys.org/news/2020-05-total-synthesis-cotylenin-anticancer-drug.html

[5] https://academic.oup.com/bbb/article/62/9/1815/5946365

[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890574/

[7] https://www.spandidos-publications.com/10.3892/or.2016.4867

[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410757/

[9] https://www.news-medical.net/news/20200513/Scientists-develop-new-method-to-synthesize-cotylenin-A.aspx

[10] https://www.spandidos-publications.com/10.3892/ijo.2014.2760

[11] https://www.sciencedirect.com/science/article/pii/S0006291X9797385X

[12] https://aacrjournals.org/cancerres/article/63/13/3659/510169/Cotylenin-A-a-Differentiation-inducing-Agent-and

[13] https://www.spandidos-publications.com/10.3892/ijo.2018.4350

[14] https://pubmed.ncbi.nlm.nih.gov/23808890/

[15] https://pubchem.ncbi.nlm.nih.gov/compound/Cotylenin-A

[16] https://www.tandfonline.com/doi/abs/10.1080/10428190290026222

[17] https://pubs.acs.org/doi/abs/10.1021/jacs.0c01774

[18] https://iovs.arvojournals.org/article.aspx?articleid=2378493

[19] https://www.sciencedirect.com/science/article/abs/pii/S0006291X9797385X

[20] https://capricorn.bc.edu/lsy/public_html/files/total-synthesis/2020-04-14_Jiangpeng_Liu_CotyleninA.pdf